摘要
目的:研究慢性胃炎患者选择雷贝拉唑联合莫沙必利治疗的效果以及对睡眠质量的影响。方法:选取2019年1月至2020年8月谷城县人民医院收治的慢性胃炎患者68例作为研究对象,按照随机单盲方法分为对照组和观察组,每组34例。对照组患者选择雷贝拉唑药物治疗,观察组在对照组基础上联合莫沙必利,分析不同方案对患者的影响。结果:观察组患者治疗有效率优于对照组,治疗后,观察组患者的睡眠质量评分低于对照组,上腹疼痛缓解时间、嗳气缓解时间、恶心呕吐缓解时间短于对照组,差异有统计学意义(P<0.05)。结论:雷贝拉唑联合莫沙必利是治疗慢性胃炎的有效方案,能改善患者的睡眠情况,提升疗效,在治疗中要重视。
Objective:To study the effect of rabeprazole combined with mosapride in treatment of chronic gastritis and its influence on sleep quality.Methods:A total of 68 patients with chronic gastritis in Gucheng People′s Hospital from January 2019 to August 2020 were selected as the research objects and randomly divided into control group and observation group,34 cases in each group.Patients in the control group were treated with rabeprazole,while patients in the observation group were treated with mosapride on the basis of the control group.Analyze the influence of different therapy on patients.Results:The effective rate of patients in the observation group was better than that of the control group.After treatment,the sleep quality score of patients in the observation group was lower than that of the control group,and the relief time of upper abdominal pain,belching,nausea and vomiting was shorter than that of the control group,with statistically significant data(P<0.05).Conclusion:Rabeprazole combined with mosapride is an effective regimen for the treatment of chronic gastritis,which can improve the sleep condition of patients and enhance the curative effect.Therefore,attention should be paid to it in the treatment.
作者
余凤婷
YU Fengting(Gucheng People′s Hospital,Gucheng 441700,China)
出处
《世界睡眠医学杂志》
2021年第4期582-583,共2页
World Journal of Sleep Medicine
关键词
慢性胃炎
雷贝拉唑
莫沙必利
睡眠质量
不良反应
Chronic gastritis
Rabeprazole
Mosapride
Sleep quality
Adverse reactions